Strengths and limitations of model systems for the study of urinary tract infections and related pathologies

Microbiology and Molecular Biology Reviews

Volumn 80, Issue 2, 2016, Pages 351-367

  Barber, Amelia E ^a   Norton, J Paul ^a   Wiles, Travis J ^a   Mulvey, Matthew A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL VIRULENCE; BIRD; CAENORHABDITIS ELEGANS; CELL CULTURE; HUMAN; LIFE CYCLE; MURINE; NONHUMAN; RECURRENT INFECTION; URINARY TRACT INFECTION; UROSEPSIS; ZEBRA FISH; ANIMAL; DISEASE MODEL; DISEASE RESISTANCE; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; URINARY TRACT; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; HUMANS; URINARY TRACT; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84973316138     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00067-15     Document Type: Article

References (254)

1. Foxman B. 2010. The epidemiology of urinary tract infection. Nat Rev Urol 7:653-660. http://dx.doi.org/10.1038/nrurol.2010.190.
2. Dielubanza EJ, Schaeffer AJ. 2011. Urinary tract infections in women. Med Clin North Am 95:27-41. http://dx.doi.org/10.1016/j.mcna.2010.08.023.
3. Brown P, Ki M, Foxman B. 2005. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics 23:1123-1142. http://dx.doi.org/10.2165/00019053-200523110-00005.
4. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections duetoEscherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5:449-456. http://dx.doi.org/10.1016/S1286-4579 (03) 00049-2.
5. Foxman B. 1990. Recurring urinary tract infection: incidence and risk factors. AmJ Public Health 80:331-333. http://dx.doi.org/10.2105/AJPH.80.3.331.
6. Jahnukainen T, Chen M, Celsi G. 2005. Mechanisms of renal damage owing to infection. Pediatr Nephrol 20:1043-1053. http://dx.doi.org/10.1007/s00467-005-1898-5.
7. Shaikh N, Craig JC, Rovers MM, Da Dalt L, Gardikis S, Hoberman A, Montini G, Rodrigo C, Taskinen S, Tuerlinckx D, Shope T. 2014. Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data. JAMA Pediatr 168:893-900. http://dx.doi.org/10.1001/jamapediatrics.2014.637.
8. Wagenlehner FM, Pilatz A, Weidner W. 2011. Urosepsis-from the view ofthe urologist. Int JAntimicrob Agents 38(Suppl):51-57. http://dx.doi.org/10.1016/j.ijantimicag.2011.09.007.
9. Smith JL, Fratamico PM, Gunther NW. 2007. Extraintestinal pathogenic Escherichia coli. Foodborne Pathog Dis 4:134-163. http://dx.doi.org/10.1089/fpd.2007.0087.
10. Barber AE, Norton JP, Spivak AM, Mulvey MA. 2013. Urinary tract infections: current and emerging management strategies. Clin Infect Dis 57:719-724. http://dx.doi.org/10.1093/cid/cit284.
11. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE. 2011. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103-e120. http://dx.doi.org/10.1093/cid/ciq257.
12. Shepherd AK, Pottinger PS. 2013. Management of urinary tract infections in the era of increasing antimicrobial resistance. Med Clin North Am 97:737-757. http://dx.doi.org/10.1016/j.mcna.2013.03.006.
13. CDC. 2013. Antibiotic resistance threats in the United States, 2013. CDC, Atlanta, GA.
14. WHO. 2014. Antimicrobial resistance: global report on surveillance. WHO, Geneva, Switzerland.
15. Pitout JD. 2012. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment. Expert Rev Anti Infect Ther 10:1165-1176. http://dx.doi.org/10.1586/eri.12.110.
16. Ronald A. 2002. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113(Suppl 1A):14S-19S.
17. Colgan R, Williams M, Johnson JR. 2011. Diagnosis and treatment of acute pyelonephritis in women. Am Fam Physician 84:519-526.
18. Touchon M, Hoede C, Tenaillon O, Barbe V, Baeriswyl S, Bidet P, Bingen E, Bonacorsi S, Bouchier C, Bouvet O, Calteau A, Chiapello H, Clermont O, Cruveiller S, Danchin A, Diard M, Dossat C, Karoui ME, Frapy E, Garry L, Ghigo JM, Gilles AM, Johnson J, Le Bouguenec C, Lescat M, Mangenot S, Martinez-Jehanne V, Matic I, Nassif X, Oztas S, Petit MA, Pichon C, Rouy Z, Ruf CS, Schneider D, Tourret J, Vacherie B, Vallenet D, Medigue C, Rocha EP, Denamur E. 2009. Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet 5:e1000344. http://dx.doi.org/10.1371/journal.pgen. 1000344.
19. Salipante SJ, Roach DJ, Kitzman JO, Snyder MW, Stackhouse B, Butler-Wu SM, Lee C, Cookson BT, Shendure J. 2015. Large-scale genomic sequencing of extraintestinal pathogenic Escherichia coli strains. Genome Res 25:119-128. http://dx.doi.org/10.1101/gr.180190.114.
20. Yan F, Polk DB. 2004. Commensal bacteria in the gut: learning who our friends are. Curr Opin Gastroenterol 20:565-571. http://dx.doi.org/10.1097/00001574-200411000-00011.
21. Stecher B, Berry D, Loy A. 2013. Colonization resistance and microbial ecophysiology: using gnotobiotic mouse models and single-cell technology to explore the intestinal jungle. FEMS Microbiol Rev 37:793-829. http://dx.doi.org/10.1111/1574-6976.12024.
22. LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. 2013. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 24:160-168. http://dx.doi.org/10.1016/j.copbio.2012.08.005.
23. Bentley R, Meganathan R. 1982. Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol Rev 46:241-280.
24. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat Rev Microbiol 2:123-140. http://dx.doi.org/10.1038/nrmicro818.
25. Yamamoto S, Tsukamoto T, Terai A, Kurazono H, Takeda Y, Yoshida O. 1997. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J Urol 157:1127-1129. http://dx.doi.org/10.1016/S0022-5347 (01) 65154-1.
26. Russell CW, Mulvey MA. 2015. The extraintestinal pathogenic Escherichia coli factor RqlI constrains the genotoxic effects of the RecQ-like helicase RqlH. PLoS Pathog 11:e1005317. http://dx.doi.org/10.1371/journal.ppat.1005317.
27. Chen SL, Wu M, Henderson JP, Hooton TM, Hibbing ME, Hultgren SJ, Gordon JI. 2013. Genomic diversity and fitness of E. Coli strains recovered from the intestinal and urinary tractsof women with recurrent urinary tract infection. Sci Transl Med 5:184ra160. http://dx.doi.org/10.1126/scitranslmed.3005497.
28. Katouli M. 2010. Population structure of gut Escherichia coli and its role in development of extra-intestinal infections. Iran J Microbiol 2:59-72.
29. Banerjee R, Johnson JR. 2014. A new clone sweeps clean: the enigmatic emergence of Escherichia colisequence type 131. Antimicrob Agents Chemother 58:4997-5004. http://dx.doi.org/10.1128/AAC.02824-14.
30. Novais A, Pires J, Ferreira H, Costa L, Montenegro C, Vuotto C, Donelli G, Coque TM, Peixe L. 2012. Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010). Antimicrob Agents Chemother 56:3973-3976. http://dx.doi.org/10.1128/AAC.00475-12.
31. Johnson JR, Nicolas-Chanoine MH, DebRoy C, Castanheira M, Robicsek A, Hansen G, Weissman S, Urban C, Platell J, Trott D, Zhanel G, Clabots C, Johnston BD, Kuskowski MA. 2012. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 18:598-607. http://dx.doi.org/10.3201/eid1804.111627.
32. Petty NK, Ben Zakour NL, Stanton-Cook M, Skippington E, Totsika M, Forde BM, Phan MD, Gomes Moriel D, Peters KM, Davies M, Rogers BA, Dougan G, Rodriguez-Bano J, Pascual A, Pitout JD, Upton M, Paterson DL, Walsh TR, Schembri MA, Beatson SA. 2014. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci U S A 111:5694-5699. http://dx.doi.org/10.1073/pnas.1322678111.
33. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66:1-14. http://dx.doi.org/10.1093/jac/dkq415.
34. Wiles TJ, Kulesus RR, Mulvey MA. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol 85:11-19. http://dx.doi.org/10.1016/j.yexmp. 2008.03.007.
35. Weichhart T, Haidinger M, Horl WH, Saemann MD. 2008. Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur J Clin Invest 38(Suppl 2):29-38. http://dx.doi.org/10.1111/j.1365-2362.2008.02006.x.
36. Brown PD, Foxman B. 2000. Pathogenesis of urinary tract infection: the role of sexual behavior and sexual transmission. Curr Infect Dis Rep 2:513-517. http://dx.doi.org/10.1007/s11908-000-0054-4.
37. Kirjavainen PV, Pautler S, Baroja ML, Anukam K, Crowley K, Carter K, Reid G. 2009. Abnormal immunological profile and vaginal microbiota in women prone to urinary tract infections. Clin Vaccine Immunol 16:29-36. http://dx.doi.org/10.1128/CVI.00323-08.
38. Darouiche RO, Hull RA. 2012. Bacterial interference for prevention of urinary tract infection. Clin Infect Dis 55:1400-1407. http://dx.doi.org/10.1093/cid/cis639.
39. Kalyoussef S, Nieves E, Dinerman E, Carpenter C, Shankar V, Oh J, Burd B, Angeletti RH, Buckheit KW, Fredricks DN, Madan RP, Keller MJ, Herold BC. 2012. Lactobacillus proteins are associated with the bactericidal activity against E. Coli of female genital tract secretions. PLoS One 7:e49506. http://dx.doi.org/10.1371/journal.pone.0049506.
40. Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S. 2015. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol 6:81. http://dx.doi.org/10.3389/fphys.2015.00081.
41. Cadieux PA, Burton J, Devillard E, Reid G. 2009. Lactobacillus byproducts inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 60(Suppl 6):13-18.
42. Brubaker L, Wolfe AJ. 2015. The new world of the urinary microbiota in women. Am J Obstet Gynecol 213:644-649. http://dx.doi.org/10.1016/j.ajog.2015.05.032.
43. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. 2000. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A 97:8829-8835. http://dx.doi.org/10.1073/pnas.97.16.8829.
44. Ragnarsdottir B, Lutay N, Gronberg-Hernandez J, Koves B, Svanborg C. 2011. Genetics of innate immunity and UTI susceptibility. Nat Rev Urol 8:449-468. http://dx.doi.org/10.1038/nrurol.2011.100.
45. Ginsberg D. 2013. The epidemiology and pathophysiology of neurogenic bladder. Am J Manag Care 19:s191-s196.
46. Gordon DM, Riley MA. 1992. A theoretical and experimental analysis of bacterial growth in the bladder. Mol Microbiol 6:555-562. http://dx.doi.org/10.1111/j.1365-2958.1992.tb01500.x.
47. Klemm P, Roos V, Ulett GC, Svanborg C, Schembri MA. 2006. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect Immun 74:781-785. http://dx.doi.org/10.1128/IAI.74.1.781-785.2006.
48. Nesta B, Spraggon G, Alteri C, Moriel DG, Rosini R, Veggi D, Smith S, Bertoldi I, Pastorello I, Ferlenghi I, Fontana MR, Frankel G, Mobley HL, Rappuoli R, Pizza M, Serino L, Soriani M. 2012. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. mBio 3:e00010-12. http://dx.doi.org/10.1128/mBio.00010-12.
49. Spurbeck RR, Stapleton AE, Johnson JR, Walk ST, Hooton TM, Mobley HL. 2011. Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae. Infect Immun 79:4753-4763. http://dx.doi.org/10.1128/IAI.05621-11.
50. Wurpel DJ, Beatson SA, Totsika M, Petty NK, Schembri MA. 2013. Chaperone-usher fimbriae of Escherichia coli. PLoS One 8:e52835. http://dx.doi.org/10.1371/journal.pone.0052835.
51. Dhakal BK, Kulesus RR, Mulvey MA. 2008. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest 38(Suppl 2):2-11. http://dx.doi.org/10.1111/j.1365-2362.2008.01986.x.
52. Hurst RE. 1994. Structure, function, and pathology ofproteoglycans and glycosaminoglycans in the urinary tract. World J Urol 12:3-10.
53. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H. 1990. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139-142.
54. Parsons CL, Greenspan C, Moore SW, Mulholland SG. 1977. Role of surface mucin inprimary antibacterial defenseofbladder. Urology 9:48-52. http://dx.doi.org/10.1016/0090-4295 (77) 90284-9.
55. Apodaca G. 2004. The uroepithelium: not just a passive barrier. Traffic 5:117-128. http://dx.doi.org/10.1046/j.1600-0854.2003.00156.x.
56. Wu XR, Kong XP, Pellicer A, Kreibich G, Sun TT. 2009. Uroplakins in urothelial biology, function, and disease. Kidney Int 75:1153-1165. http://dx.doi.org/10.1038/ki.2009.73.
57. Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu XR, Sun TT, Kong XP. 2001. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci 114:4095-4103.
58. Eto DS, Jones TA, Sundsbak JL, Mulvey MA. 2007. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 3:e100. http://dx.doi.org/10.1371/journal.ppat.0030100.
59. Leusch HG, Drzeniek Z, Markos-Pusztai Z, Wagener C. 1991. Binding of Escherichia coli and Salmonella strains to members of the carcinoembryonic antigen family: differential binding inhibition by aromatic alpha-glycosides of mannose. Infect Immun 59:2051-2057.
60. Pouttu R, Puustinen T, Virkola R, Hacker J, Klemm P, Korhonen TK. 1999. Amino acid residue Ala-62 in the FimH fimbrial adhesin is critical for the adhesiveness of meningitis-associated Escherichia coli to collagens. Mol Microbiol 31:1747-1757. http://dx.doi.org/10.1046/j.1365-2958.1999.01311.x.
61. Gbarah A, Gahmberg CG, Ofek I, Jacobi U, Sharon N. 1991. Identification of the leukocyte adhesion molecules CD11 and CD18 as receptors for type 1-fimbriated (mannose-specific) Escherichia coli. Infect Immun 59:4524-4530.
62. Sokurenko EV, Courtney HS, Abraham SN, Klemm P, Hasty DL. 1992. Functional heterogeneity of type 1 fimbriae of Escherichia coli. Infect Immun 60:4709-4719.
63. Cegelski L, Pinkner JS, Hammer ND, Cusumano CK, Hung CS, Chorell E, Aberg V, Walker JN, Seed PC, Almqvist F, Chapman MR, Hultgren SJ. 2009. Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol 5:913-919. http://dx.doi.org/10.1038/nchembio.242.
64. Floyd KA, Moore JL, Eberly AR, Good JA, Shaffer CL, Zaver H, Almqvist F, Skaar EP, Caprioli RM, Hadjifrangiskou M. 2015. Adhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 pili. PLoS Pathog 11:e1004697. http://dx.doi.org/10.1371/journal.ppat.1004697.
65. Allsopp LP, Beloin C, Ulett GC, Valle J, Totsika M, Sherlock O, Ghigo JM, Schembri MA. 2012. Molecular characterization of UpaB and UpaC, two new autotransporter proteins of uropathogenic Escherichia coli CFT073. Infect Immun 80:321-332. http://dx.doi.org/10.1128/IAI.05322-11.
66. Ulett GC, Valle J, Beloin C, Sherlock O, Ghigo JM, Schembri MA. 2007. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun 75:3233-3244. http://dx.doi.org/10.1128/IAI.01952-06.
67. Hadjifrangiskou M, Gu AP, Pinkner JS, Kostakioti M, Zhang EW, Greene SE, Hultgren SJ. 2012. Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. J Bacteriol 194:6195-6205. http://dx.doi.org/10.1128/JB.01012-12.
68. Valle J, Mabbett AN, Ulett GC, Toledo-Arana A, Wecker K, Totsika M, Schembri MA, Ghigo JM, Beloin C. 2008. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J Bacteriol 190:4147-4161. http://dx.doi.org/10.1128/JB.00122-08.
69. Reisner A, Maierl M, Jorger M, Krause R, Berger D, Haid A, Tesic D, Zechner EL. 2014. Type 1 fimbriae contribute to catheter-associated urinary tract infections caused by Escherichia coli. J Bacteriol 196:931-939. http://dx.doi.org/10.1128/JB.00985-13.
70. Hung C, Zhou Y, Pinkner JS, Dodson KW, Crowley JR, Heuser J, Chapman MR, Hadjifrangiskou M, Henderson JP, Hultgren SJ. 2013. Escherichia coli biofilms have an organized and complex extracellular matrix structure. mBio 4:e00645-13. http://dx.doi.org/10.1128/mBio.00645-13.
71. Melican K, Richter-Dahlfors A. 2009. Real-time live imaging to study bacterial infections in vivo. Curr Opin Microbiol 12:31-36. http://dx.doi.org/10.1016/j.mib.2008.11.002.
72. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ. 2000. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J 19:2803-2812. http://dx.doi.org/10.1093/emboj/19.12.2803.
73. Plancon L, Du Merle L, Le Friec S, Gounon P, Jouve M, Guignot J, Servin A, Le Bouguenec C. 2003. Recognition of the cellular beta1-chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa-expressing pathogenic Escherichia coli strains. Cell Microbiol 5:681-693. http://dx.doi.org/10.1046/j.1462-5822.2003.00308.x.
74. Guignot J, Bernet-Camard MF, Pous C, Plancon L, Le Bouguenec C, Servin AL. 2001. Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules. Infect Immun 69:1856-1868. http://dx.doi.org/10.1128/IAI.69.3.1856-1868.2001.
75. Springall T, Sheerin NS, Abe K, Holers VM, Wan H, Sacks SH. 2001. Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat Med 7:801-806. http://dx.doi.org/10.1038/89923.
76. Li K, Feito MJ, Sacks SH, Sheerin NS. 2006. CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli. J Immunol 177:2543-2551. http://dx.doi.org/10.4049/jimmunol.177.4.2543.
77. Rana T, Hasan RJ, Nowicki S, Venkatarajan MS, Singh R, Urvil PT, Popov V, Braun WA, Popik W, Goodwin JS, Nowicki BJ. 2014. Complement protective epitopes and CD55-microtubule complexes facilitate the invasion and intracellular persistence of uropathogenic Escherichia coli. J Infect Dis 209:1066-1076. http://dx.doi.org/10.1093/infdis/jit619.
78. Servin AL. 2005. Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev 18:264-292. http://dx.doi.org/10.1128/CMR.18.2.264-292.2005.
79. Nowicki B, Selvarangan R, Nowicki S. 2001. Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J Infect Dis 183(Suppl 1):S24-S27. http://dx.doi.org/10.1086/318846.
80. Bens M, Vimont S, Mkaddem SB, Chassin C, Goujon JM, Balloy V, Chignard M, Werts C, Vandewalle A. 2014. Flagellin/TLR5 signaling activates renal collecting duct cells and facilitates invasion and cellular translocation of uropathogenic Escherichia coli. Cell Microbiol 16:1503-1517. http://dx.doi.org/10.1111/cmi.12306.
81. Chassin C, Vimont S, Cluzeaud F, Bens M, Goujon JM, Fernandez B, Hertig A, Rondeau E, Arlet G, Hornef MW, Vandewalle A. 2008. TLR4 facilitates translocation of bacteria across renal collecting duct cells. J Am Soc Nephrol 19:2364-2374. http://dx.doi.org/10.1681/ASN.2007121273.
82. Bishop BL, Duncan MJ, Song J, Li G, Zaas D, Abraham SN. 2007. Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 13:625-630. http://dx.doi.org/10.1038/nm1572.
83. Mulvey MA, Schilling JD, Hultgren SJ. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 69:4572-4579. http://dx.doi.org/10.1128/IAI.69.7.4572-4579.2001.
84. Eto DS, Sundsbak JL, Mulvey MA. 2006. Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol 8:704-717. http://dx.doi.org/10.1111/j.1462-5822.2006.00691.x.
85. Mysorekar IU, Hultgren SJ. 2006. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A 103:14170-14175. http://dx.doi.org/10.1073/pnas.0602136103.
86. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105-107. http://dx.doi.org/10.1126/science.1084550.
87. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer MJ, Hultgren SJ. 2004. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 101:1333-1338. http://dx.doi.org/10.1073/pnas.0308125100.
88. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ. 1998. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494-1497. http://dx.doi.org/10.1126/science.282.5393.1494.
89. Blango MG, Ott EM, Erman A, Veranic P, Mulvey MA. 2014. Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs. PLoS One 9:e93327. http://dx.doi.org/10.1371/journal.pone.0093327.
90. Dikshit N, Bist P, Fenlon SN, Pulloor NK, Chua CE, Scidmore MA, Carlyon JA, Tang BL, Chen SL, Sukumaran B. 2015. Intracellular uropathogenic E. Coli exploits host Rab35 for iron acquisition and survival within urinary bladder cells. PLoS Pathog 11:e1005083. http://dx.doi.org/10.1371/journal.ppat.1005083.
91. Schilling JD, Lorenz RG, Hultgren SJ. 2002. Effect of trimethoprimsulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 70:7042-7049. http://dx.doi.org/10.1128/IAI.70.12.7042-7049.2002.
92. Blango MG, Mulvey MA. 2010. Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother 54:1855-1863. http://dx.doi.org/10.1128/AAC.00014-10.
93. Berry RE, Klumpp DJ, Schaeffer AJ. 2009. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun 77:2762-2772. http://dx.doi.org/10.1128/IAI.00323-09.
94. Justice SS, Hunstad DA, Seed PC, Hultgren SJ. 2006. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc Natl Acad Sci U S A 103:19884-19889. http://dx.doi.org/10.1073/pnas.0606329104.
95. Bower JM, Eto DS, Mulvey MA. 2005. Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic 6:18-31. http://dx.doi.org/10.1111/j.1600-0854.2004.00251.x.
96. Alteri CJ, Smith SN, Mobley HL. 2009. Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog 5:e1000448. http://dx.doi.org/10.1371/journal.ppat.1000448.
97. Sivick KE, Mobley HL. 2010. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect Immun 78:568-585. http://dx.doi.org/10.1128/IAI.01000-09.
98. Wiles TJ, Mulvey MA. 2013. The RTX pore-forming toxin alphahemolysin of uropathogenic Escherichia coli: progress and perspectives. Future Microbiol 8:73-84. http://dx.doi.org/10.2217/fmb.12.131.
99. Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, Stamm WE, Hooton TM, Hultgren SJ. 2009. Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli. PLoS Pathog 5:e1000305. http://dx.doi.org/10.1371/journal.ppat.1000305.
100. Singer RS. 2015. Urinary tract infections attributed to diverse ExPEC strains in food animals: evidence and data gaps. Front Microbiol 6:28. http://dx.doi.org/10.3389/fmicb.2015.00028.
101. Luo C, Walk ST, Gordon DM, Feldgarden M, Tiedje JM, Konstantinidis KT. 2011. Genome sequencing of environmental Escherichia coli expands understanding of the ecology and speciation of the model bacterial species. Proc Natl Acad Sci U S A 108:7200-7205. http://dx.doi.org/10.1073/pnas.1015622108.
102. Chandran A, Hatha AA, Varghese S, Sheeja KM. 2008. Prevalence of multiple drug resistant Escherichia coli serotypes in a tropical estuary, India. Microbes Environ 23:153-158. http://dx.doi.org/10.1264/jsme2.23.153.
103. Anastasi EM, Matthews B, Stratton HM, Katouli M. 2012. Pathogenic Escherichia coli found in sewage treatment plants and environmental waters. Appl Environ Microbiol 78:5536-5541. http://dx.doi.org/10.1128/AEM.00657-12.
104. Anastasi EM, Wohlsen TD, Stratton HM, Katouli M. 2013. Survival of Escherichia coli intwo sewage treatment plants using UVirradiation and chlorination for disinfection. Water Res 47:6670-6679. http://dx.doi.org/10.1016/j.watres.2013.09.008.
105. Gundogdu A, Jennison AV, Smith HV, Stratton H, Katouli M. 2013. Extended-spectrum beta-lactamase producing Escherichia coli in hospital wastewaters and sewage treatment plants in Queensland, Australia. Can J Microbiol 59:737-745. http://dx.doi.org/10.1139/cjm-2013-0515.
106. Belanger L, Garenaux A, Harel J, Boulianne M, Nadeau E, Dozois CM. 2011. Escherichia coli from animal reservoirs as a potential source of human extraintestinal pathogenic E. Coli. FEMS Immunol Med Microbiol 62:1-10. http://dx.doi.org/10.1111/j.1574-695X.2011.00797.x.
107. Manges AR, Smith SP, Lau BJ, Nuval CJ, Eisenberg JN, Dietrich PS, Riley LW. 2007. Retail meat consumption and the acquisition of antimicrobial resistant Escherichia coli causing urinary tract infections: a case-control study. Foodborne Pathog Dis 4:419-431. http://dx.doi.org/10.1089/fpd.2007.0026.
108. Jakobsen L, Kurbasic A, Skjot-Rasmussen L, Ejrnaes K, Porsbo LJ, Pedersen K, Jensen LB, Emborg HD, Agerso Y, Olsen KE, Aarestrup FM, Frimodt-Moller N, Hammerum AM. 2010. Escherichia coli isolates from broiler chicken meat, broiler chickens, pork, and pigs share phylogroups and antimicrobial resistance with community-dwelling humans and patients with urinary tract infection. Foodborne Pathog Dis 7:537-547. http://dx.doi.org/10.1089/fpd.2009.0409.
109. Jakobsen L, Garneau P, Bruant G, Harel J, Olsen SS, Porsbo LJ, Hammerum AM, Frimodt-Moller N. 2012. Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis 31:1121-1129. http://dx.doi.org/10.1007/s10096-011-1417-5.
110. Jakobsen L, Spangholm DJ, Pedersen K, Jensen LB, Emborg HD, Agerso Y, Aarestrup FM, Hammerum AM, Frimodt-Moller N. 2010. Broiler chickens, broiler chicken meat, pigs and porkassources of ExPEC related virulence genes and resistance in Escherichia coli isolates from community-dwelling humans and UTI patients. Int J Food Microbiol 142:264-272. http://dx.doi.org/10.1016/j.ijfoodmicro.2010.06.025.
111. Guiton PS, Hannan TJ, Ford B, Caparon MG, Hultgren SJ. 2013. Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections. Infect Immun 81:329-339. http://dx.doi.org/10.1128/IAI.00856-12.
112. Rosen DA, Pinkner JS, Jones JM, Walker JN, Clegg S, Hultgren SJ. 2008. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect Immun 76:3337-3345. http://dx.doi.org/10.1128/IAI.00090-08.
113. Murphy CN, Mortensen MS, Krogfelt KA, Clegg S. 2013. Role of Klebsiella pneumoniae type 1 and type 3 fimbriae in colonizing silicone tubes implanted into the bladders of mice as a model of catheterassociated urinary tract infections. Infect Immun 81:3009-3017. http://dx.doi.org/10.1128/IAI.00348-13.
114. Bialek S, Lavigne JP, Chevalier J, Marcon E, Leflon-Guibout V, Davin A, Moreau R, Pages JM, Nicolas-Chanoine MH. 2010. Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model. Antimicrob Agents Chemother 54:4373-4378. http://dx.doi.org/10.1128/AAC.01607-09.
115. Prajsnar TK, Renshaw SA, Ogryzko NV, Foster SJ, Serror P, Mesnage S. 2013. Zebrafish as a novel vertebrate model to dissect enterococcal pathogenesis. Infect Immun 81:4271-4279. http://dx.doi.org/10.1128/IAI.00976-13.
116. Bode NJ, Debnath I, Kuan L, Schulfer A, Ty M, Pearson MM. 2015. Transcriptional analysis of the MrpJ network: modulation of diverse virulence-associated genes and direct regulation of mrp fimbrial and flhDC flagellar operons in Proteus mirabilis. Infect Immun 83:2542-2556. http://dx.doi.org/10.1128/IAI.02978-14.
117. Lebreton F, Riboulet-Bisson E, Serror P, Sanguinetti M, Posteraro B, Torelli R, Hartke A, Auffray Y, Giard JC. 2009. ace, which encodes an adhesin in Enterococcus faecalis, is regulated by Ers and is involved in virulence. Infect Immun 77:2832-2839. http://dx.doi.org/10.1128/IAI.01218-08.
118. Arthur M, Johnson CE, Rubin RH, Arbeit C, Campanelli C, Kim C, Steinbach S, Agarwal M, Wilkinson R, Goldstein R. 1989. Moleclar epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun 57:303-313.
119. Johnson JR, Urban C, Weissman SJ, Jorgensen JH, Lewis JS, II, Hansen G, Edelstein PH, Robicsek A, Cleary T, Adachi J, Paterson D, Quinn J, Hanson ND, Johnston BD, Clabots C, Kuskowski MA, AMERECUS Investigators. 2012. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-beta-lactamase-producing E. Coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 56:2364-2370. http://dx.doi.org/10.1128/AAC.05824-11.
120. Yamamoto S. 2007. Molecular epidemiology of uropathogenic Escherichia coli. J Infect Chemother 13:68-73. http://dx.doi.org/10.1007/s10156-007-0506-Y.
121. Datta P, Gupta V, Arora S, Garg S, Chander J. 2014. Epidemiology of extended-spectrum beta-lactamase, AmpC, and carbapenemase production in Proteus mirabilis. Jpn J Infect Dis 67:44-46. http://dx.doi.org/10.7883/yoken. 67.44.
122. Johnson JR, Russo TA. 2005. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 295:383-404. http://dx.doi.org/10.1016/j.ijmm.2005.07.005.
123. Poey ME, Lavina M. 2014. Integrons in uropathogenic Escherichia coli and their relationship with phylogeny and virulence. Microb Pathog 77:73-77. http://dx.doi.org/10.1016/j.micpath.2014.11.002.
124. Price LB, Johnson JR, Aziz M, Clabots C, Johnston B, Tchesnokova V, Nordstrom L, Billig M, Chattopadhyay S, Stegger M, Andersen PS, Pearson T, Riddell K, Rogers P, Scholes D, Kahl B, Keim P, Sokurenko EV. 2013. The epidemic of extended-spectrum-beta-lactamaseproducing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4:e00377-13. http://dx.doi.org/10.1128/mBio.00377-13.
125. Vollmerhausen TL, Katouli M. 2014. Molecular characterisation of Escherichia coli isolated from hospitalised children and adults with urinary tract infection. Eur J Clin Microbiol Infect Dis 33:975-982. http://dx.doi.org/10.1007/s10096-013-2035-1.
126. Tapiainen T, Hanni AM, Salo J, Ikaheimo I, Uhari M. 2014. Escherichia coli biofilm formation and recurrences of urinary tract infections in children. Eur J Clin Microbiol Infect Dis 33:111-115. http://dx.doi.org/10.1007/s10096-013-1935-4.
127. Connell I, Agace W, Klemm P, Schembri M, Marild S, Svanborg C. 1996. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 93:9827-9832. http://dx.doi.org/10.1073/pnas.93.18.9827.
128. Connell H, Agace W, Hedlund M, Klemm P, Shembri M, Svanborg C. 1996. Fimbriae-mediated adherence induces mucosal inflammation and bacterial clearance. Consequences for anti-adhesion therapy. Adv Exp Med Biol 408:73-80. http://dx.doi.org/10.1007/978-1-4613-0415-9-9.
129. Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ. 2001. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J Immunol 166:1148-1155. http://dx.doi.org/10.4049/jimmunol.166.2.1148.
130. Subashchandrabose S, Hazen TH, Brumbaugh AR, Himpsl SD, Smith SN, Ernst RD, Rasko DA, Mobley HL. 2014. Host-specific induction of Escherichia coli fitness genes during human urinary tract infection. Proc Natl Acad Sci U S A 111:18327-18332. http://dx.doi.org/10.1073/pnas.1415959112.
131. Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ. 2007. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4:e329. http://dx.doi.org/10.1371/journal.pmed.0040329.
132. Khasriya R, Sathiananthamoorthy S, Ismail S, Kelsey M, Wilson M, Rohn JL, Malone-Lee J. 2013. Spectrum of bacterial colonization associated with urothelial cells from patients with chronic lower urinary tract symptoms. J Clin Microbiol 51:2054-2062. http://dx.doi.org/10.1128/JCM.03314-12.
133. Robino L, Scavone P, Araujo L, Algorta G, Zunino P, Vignoli R. 2013. Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections. Pathog Dis 68:78-81. http://dx.doi.org/10.1111/2049-632X.12047.
134. Robino L, Scavone P, Araujo L, Algorta G, Zunino P, Pirez MC, Vignoli R. 2014. Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children. Clin Infect Dis 59:e158-e164. http://dx.doi.org/10.1093/cid/ciu634.
135. Scott VC, Haake DA, Churchill BM, Justice SS, Kim JH. 2015. Intracellular bacterial communities: a potential etiology for chronic lower urinary tract symptoms. Urology 86:425-431. http://dx.doi.org/10.1016/j.urology.2015.04.002.
136. Moura A, Nicolau A, Hooton T, Azeredo J. 2009. Antibiotherapy and pathogenesis of uncomplicated UTI: difficult relationships. J Appl Microbiol 106:1779-1791. http://dx.doi.org/10.1111/j.1365-2672.2008.04115.x.
137. Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, Stergachis A, Stamm WE. 1996. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 335:468-474. http://dx.doi.org/10.1056/NEJM199608153350703.
138. Handley MA, Reingold AL, Shiboski S, Padian NS. 2002. Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides. Epidemiology 13:431-436. http://dx.doi.org/10.1097/00001648-200207000-00011.
139. Smith HS, Hughes JP, Hooton TM, Roberts P, Scholes D, Stergachis A, Stapleton A, Stamm WE. 1997. Antecedent antimicrobial use increases the risk of uncomplicated cystitis in young women. Clin Infect Dis 25:63-68. http://dx.doi.org/10.1086/514502.
140. Hillier S, Roberts Z, Dunstan F, Butler C, Howard A, Palmer S. 2007. Prior antibiotics and risk of antibiotic-resistant community-acquired urinary tract infection: a case-control study. J Antimicrob Chemother 60:92-99. http://dx.doi.org/10.1093/jac/dkm141.
141. Darouiche RO, Donovan WH, Del Terzo M, Thornby JI, Rudy DC, Hull RA. 2001. Pilot trial of bacterial interference for preventing urinary tract infection. Urology 58:339-344. http://dx.doi.org/10.1016/S0090-4295 (01) 01271-7.
142. Stamm WE, Raz R. 1999. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 28:723-725. http://dx.doi.org/10.1086/515209.
143. Ghartey JP, Carpenter C, Gialanella P, Rising C, McAndrew TC, Mhatre M, Tugetman J, Einstein MH, Chazotte C, Herold BC. 2012. Association of bactericidal activity of genital tract secretions with Escherichia coli colonization in pregnancy. Am J Obstet Gynecol 207:297.e1-297.e8. http://dx.doi.org/10.1016/j.ajog.2012.07.025.
144. Mazor-Dray E, Levy A, Schlaeffer F, Sheiner E. 2009. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med 22:124-128. http://dx.doi.org/10.1080/14767050802488246.
145. Bolton M, Horvath DJ, Jr, Li B, Cortado H, Newsom D, White P, Partida-Sanchez S, Justice SS. 2012. Intrauterine growth restriction is a direct consequence of localized maternal uropathogenic Escherichia coli cystitis. PLoS One 7:e33897. http://dx.doi.org/10.1371/journal.pone.0033897.
146. Kline KA, Schwartz DJ, Gilbert NM, Lewis AL. 2014. Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model. PLoS One 9:e97798. http://dx.doi.org/10.1371/journal.pone.0097798.
147. Godaly G, Ambite I, Svanborg C. 2015. Innate immunity and genetic determinants of urinary tract infection susceptibility. Curr Opin Infect Dis 28:88-96. http://dx.doi.org/10.1097/QCO.0000000000000127.
148. Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, Rogatko A, Fair WR. 1989. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 320:773-777. http://dx.doi.org/10.1056/NEJM198903233201205.
149. Schaeffer AJ, Radvany RM, Chmiel JS. 1983. Human leukocyte antigens in women with recurrent urinary tract infections. J Infect Dis 148:604. http://dx.doi.org/10.1093/infdis/148.3.604.
150. Hawn TR, Scholes D, Li SS, Wang H, Yang Y, Roberts PL, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM. 2009. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 4:e5990. http://dx.doi.org/10.1371/journal.pone.0005990.
151. Taganna J, de Boer AR, Wuhrer M, Bouckaert J. 2011. Glycosylation changes as important factors for the susceptibility to urinary tract infection. Biochem Soc Trans 39:349-354. http://dx.doi.org/10.1042/BST0390349.
152. Hopkins WJ, Heisey DM, Lorentzen DF, Uehling DT. 1998. A comparative study of major histocompatibility complex and red blood cell antigen phenotypes as risk factors for recurrent urinary tract infections in women. J Infect Dis 177:1296-1301. http://dx.doi.org/10.1086/515283.
153. Smith YC, Grande KK, Rasmussen SB, O'Brien AD. 2006. Novel three-dimensional organoid model for evaluation of the interaction of uropathogenic Escherichia coli with terminally differentiated human urothelial cells. Infect Immun 74:750-757. http://dx.doi.org/10.1128/IAI.74.1.750-757.2006.
154. Jerman UD, Veranic P, Kreft ME. 2014. Amniotic membrane scaffolds enable the development of tissue-engineered urothelium with molecular and ultrastructural properties comparable to that of native urothelium. Tissue Eng Part C Methods 20:317-327. http://dx.doi.org/10.1089/ten. tec.2013.0298.
155. Southgate J, Hutton KA, Thomas DF, Trejdosiewicz LK. 1994. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 71:583-594.
156. Lau ME, Hunstad DA. 2013. Quantitative assessment of human neutrophil migration across a cultured bladder epithelium. J Vis Exp 81:e50919. http://dx.doi.org/10.3791/50919.
157. Eto DS, Gordon HB, Dhakal BK, Jones TA, Mulvey MA. 2008. Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells. Cell Microbiol 10:2553-2567. http://dx.doi.org/10.1111/j.1462-5822.2008.01229.x.
158. Martinez JJ, Hultgren SJ. 2002. Requirement of Rho-family GTPases in the invasion of type 1-piliated uropathogenic Escherichia coli. Cell Microbiol 4:19-28. http://dx.doi.org/10.1046/j.1462-5822.2002.00166.x.
159. Thumbikat P, Berry RE, Zhou G, Billips BK, Yaggie RE, Zaichuk T, Sun TT, Schaeffer AJ, Klumpp DJ. 2009. Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog 5:e1000415. http://dx.doi.org/10.1371/journal.ppat.1000415.
160. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F. 2014. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343:84-87. http://dx.doi.org/10.1126/science.1247005.
161. Zhou Y, Zhu S, Cai C, Yuan P, Li C, Huang Y, Wei W. 2014. High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature 509:487-491. http://dx.doi.org/10.1038/nature13166.
162. Dhakal BK, Mulvey MA. 2009. Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway. J Biol Chem 284:446-454. http://dx.doi.org/10.1074/jbc. M805010200.
163. Chen TC, Tsai JP, Huang HJ, Teng CC, Chien SJ, Kuo HC, Huang WS, Chen CN. 2011. Regulation of cyclooxygenase-2 expression in human bladder epithelial cells infected with type I fimbriated uropathogenic E. Coli. Cell Microbiol 13:1703-1713. http://dx.doi.org/10.1111/j.1462-5822.2011.01650.x.
164. Song J, Bishop BL, Li G, Duncan MJ, Abraham SN. 2007. TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 1:287-298. http://dx.doi.org/10.1016/j.chom.2007.05.007.
165. Banadakoppa M, Goluszko P, Liebenthal D, Nowicki BJ, Nowicki S, Yallampalli C. 2014. PI3K/Akt pathway restricts epithelial adhesion of Dr + Escherichia coli by down-regulating the expression of decay accelerating factor. Exp Biol Med 239:581-594. http://dx.doi.org/10.1177/1535370214522183.
166. Song J, Bishop BL, Li G, Grady R, Stapleton A, Abraham SN. 2009. TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc Natl Acad Sci USA 106:14966-14971. http://dx.doi.org/10.1073/pnas.0900527106.
167. Lin AE, Beasley FC, Olson J, Keller N, Shalwitz RA, Hannan TJ, Hultgren SJ, Nizet V. 2015. Role of hypoxia inducible factor-1alpha (HIF-1alpha) in innate defense against uropathogenic Escherichia coli infection. PLoS Pathog 11:e1004818. http://dx.doi.org/10.1371/journal.ppat.1004818.
168. Li K, Zhou W, Hong Y, Sacks SH, Sheerin NS. 2009. Synergy between type 1 fimbriae expression and C3 opsonisation increases internalisation of E. Coli by human tubular epithelial cells. BMC Microbiol 9:64. http://dx.doi.org/10.1186/1471-2180-9-64.
169. Wang Z, Humphrey C, Frilot N, Wang G, Nie Z, Moniri NH, Daaka Y. 2011. Dynamin2- and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli. J Cell Biol 192:101-110. http://dx.doi.org/10.1083/jcb.201003027.
170. Hunstad DA, Justice SS, Hung CS, Lauer SR, Hultgren SJ. 2005. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun 73:3999-4006. http://dx.doi.org/10.1128/IAI.73.7.3999-4006.2005.
171. Guyer DM, Radulovic S, Jones FE, Mobley HL. 2002. Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun 70:4539-4546. http://dx.doi.org/10.1128/IAI.70.8.4539-4546.2002.
172. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, Svanborg C, Miethke T. 2008. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 14:399-406. http://dx.doi.org/10.1038/nm1734.
173. Visvikis O, Boyer L, Torrino S, Doye A, Lemonnier M, Lores P, Rolando M, Flatau G, Mettouchi A, Bouvard D, Veiga E, Gacon G, Cossart P, Lemichez E. 2011. Escherichia coli producing CNF1 toxin hijacks Tollip to trigger Rac1-dependent cell invasion. Traffic 12:579-590. http://dx.doi.org/10.1111/j.1600-0854.2011.01174.x.
174. Dhakal BK, Mulvey MA. 2012. The UPEC pore-forming toxin alphahemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe 11:58-69. http://dx.doi.org/10.1016/j.chom.2011.12.003.
175. Wiles TJ, Dhakal BK, Eto DS, Mulvey MA. 2008. Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins. Mol Biol Cell 19:1427-1438. http://dx.doi.org/10.1091/mbc. E07-07-0638.
176. Maroncle NM, Sivick KE, Brady R, Stokes FE, Mobley HL. 2006. Protease activity, secretion, cell entry, cytotoxicity, and cellular targets of secreted autotransporter toxin of uropathogenic Escherichia coli. Infect Immun 74:6124-6134. http://dx.doi.org/10.1128/IAI.01086-06.
177. Falzano L, Filippini P, Travaglione S, Miraglia AG, Fabbri A, Fiorentini C. 2006. Escherichia coli cytotoxic necrotizing factor 1 blocks cell cycle G2/M transition in uroepithelial cells. Infect Immun 74:3765-3772. http://dx.doi.org/10.1128/IAI.01413-05.
178. Laestadius A, Richter-Dahlfors A, Aperia A. 2002. Dual effects of Escherichia coli alpha-hemolysin on rat renal proximal tubule cells. Kidney Int 62:2035-2042. http://dx.doi.org/10.1046/j.1523-1755.2002.00661.x.
179. Klumpp DJ, Rycyk MT, Chen MC, Thumbikat P, Sengupta S, Schaeffer AJ. 2006. Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect Immun 74:5106-5113. http://dx.doi.org/10.1128/IAI.00376-06.
180. 2+ oscillations in renal epithelial cells. Nature 405:694-697. http://dx.doi.org/10.1038/35015091.
181. Andersen TE, Khandige S, Madelung M, Brewer J, Kolmos HJ, Moller-Jensen J. 2012. Escherichia coli uropathogenesis in vitro: invasion, cellular escape, and secondary infection analyzed in a human bladder cell infection model. Infect Immun 80:1858-1867. http://dx.doi.org/10.1128/IAI.06075-11.
182. Kreft ME, Robenek H. 2012. Freeze-fracture replica immunolabelling reveals urothelial plaques in cultured urothelial cells. PLoS One 7:e38509. http://dx.doi.org/10.1371/journal.pone.0038509.
183. Carey AJ, Tan CK, Ipe DS, Sullivan MJ, Cripps AW, Schembri MA, Ulett GC. 26 May 2015. Urinary tract infection of mice to model human disease: practicalities, implications and limitations. Crit Rev Microbiol http://dx.doi.org/10.3109/1040841X.2015.1028885.
184. Schwartz DJ, Conover MS, Hannan TJ, Hultgren SJ. 2015. UropathogenicEscherichia coli superinfection enhances the severity ofmouse bladder infection. PLoS Pathog 11:e1004599. http://dx.doi.org/10.1371/journal.ppat.1004599.
185. Conover MS, Flores-Mireles AL, Hibbing ME, Dodson K, Hultgren SJ. 2015. Establishment and characterization of UTI and CAUTI in a mouse model. J Vis Exp 2015:e52892. http://dx.doi.org/10.3791/52892.
186. Johnson DE, Lockatell CV, Hall-Craggs M, Warren JW. 1991. Mouse models of short- and long-term foreign body in the urinary bladder: analogies to the bladder segment of urinary catheters. Lab Anim Sci 41:451-455.
187. Janssen C, Lo J, Jager W, Moskalev I, Law A, Chew BH, Lange D. 2014. A high throughput, minimally invasive, ultrasound guided model for the study of catheter associated urinary tract infections and device encrustation in mice. J Urol 192:1856-1863. http://dx.doi.org/10.1016/j.juro.2014.05.092.
188. Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL. 2012. Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun 80:4186-4194. http://dx.doi.org/10.1128/IAI.00684-12.
189. Lane MC, Alteri CJ, Smith SN, Mobley HL. 2007. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract. Proc Natl Acad Sci U S A 104:16669-16674. http://dx.doi.org/10.1073/pnas.0607898104.
190. Hung CS, Dodson KW, Hultgren SJ. 2009. A murine model of urinary tract infection. Nat Protoc 4:1230-1243. http://dx.doi.org/10.1038/nprot.2009.116.
191. Kadurugamuwa JL, Modi K, Yu J, Francis KP, Purchio T, Contag PR. 2005. Noninvasive biophotonic imaging for monitoring of catheterassociated urinary tract infections and therapy in mice. Infect Immun 73:3878-3887. http://dx.doi.org/10.1128/IAI.73.7.3878-3887.2005.
192. Olson PD, Hruska KA, Hunstad DA. 8 October 2015. Androgens enhance male urinary tract infection severity in a new model. J Am Soc Nephrol http://dx.doi.org/10.1681/ASN.2015030327.
193. Koenig H, Goldstone A, Hughes C. 1978. Lysosomal enzymuria in the testosterone-treated mouse. Amanifestationofcell defecationof residual bodies. Lab Invest 39:329-341.
194. Koenig H, Goldstone A, Blume G, Lu CY. 1980. Testosterone-mediated sexual dimorphism of mitochondria and lysosomes in mouse kidney proximal tubules. Science 209:1023-1026. http://dx.doi.org/10.1126/science.7403864.
195. Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT. 1998. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect Immun 66:2798-2802.
196. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg Eden C. 1984. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 46:839-844.
197. Donovan GT, Norton JP, Bower JM, Mulvey MA. 2013. Adenylate cyclase and the cyclic AMP receptor protein modulate stress resistance and virulence capacity of uropathogenic Escherichia coli. Infect Immun 81:249-258. http://dx.doi.org/10.1128/IAI.00796-12.
198. Alteri CJ, Mobley HL. 2012. Escherichia coli physiology and metabolism dictates adaptation to diverse host microenvironments. Curr Opin Microbiol 15:3-9. http://dx.doi.org/10.1016/j.mib.2011.12.004.
199. Suhs KA, Marthaler BR, Welch RA, Hopkins WJ. 2011. Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice. mBio 2:e00094-11. http://dx.doi.org/10.1128/mBio.00094-11.
200. Hopkins WJ, Elkahwaji J, Kendziorski C, Moser AR, Briggs PM, Suhs KA. 2009. Quantitative trait loci associated with susceptibility to bladder and kidney infections induced by Escherichia coli in female C3H/HeJ mice. J Infect Dis 199:355-361. http://dx.doi.org/10.1086/595987.
201. Li B, Smith P, Horvath DJ, Jr, Romesberg FE, Justice SS. 2010. SOS regulatory elements are essential for UPEC pathogenesis. Microbes Infect 12:662-668. http://dx.doi.org/10.1016/j.micinf.2010.04.009.
202. Mansson LE, Melican K, Boekel J, Sandoval RM, Hautefort I, Tanner GA, Molitoris BA, Richter-Dahlfors A. 2007. Real-time studies of the progression of bacterial infections and immediate tissue responses in live animals. Cell Microbiol 9:413-424. http://dx.doi.org/10.1111/j.1462-5822.2006.00799.x.
203. Wiles TJ, Norton JP, Smith SN, Lewis AJ, Mobley HL, Casjens SR, Mulvey MA. 2013. A phyletically rare gene promotes the niche-specific fitness of an E.coli pathogen during bacteremia. PLoS Pathog 9:e1003175. http://dx.doi.org/10.1371/journal.ppat.1003175.
204. Wiles TJ, Norton JP, Russell CW, Dalley BK, Fischer KF, Mulvey MA. 2013. Combining quantitative genetic footprinting and trait enrichment analysis to identify fitness determinants of a bacterial pathogen. PLoS Genet 9:e1003716. http://dx.doi.org/10.1371/journal.pgen. 1003716.
205. Smith SN, Hagan EC, Lane MC, Mobley HL. 2010. Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. mBio 1:e00262-10. http://dx.doi.org/10.1128/mBio.00262-10.
206. Subashchandrabose S, Smith SN, Spurbeck RR, Kole MM, Mobley HL. 2013. Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog 9:e1003788. http://dx.doi.org/10.1371/journal.ppat.1003788.
207. Vigil PD, Wiles TJ, Engstrom MD, Prasov L, Mulvey MA, Mobley HL. 2012. The repeat-in-toxin family member TosA mediates adherence of uropathogenicEscherichia coliand survival during bacteremia. Infect Immun 80:493-505. http://dx.doi.org/10.1128/IAI.05713-11.
208. Landraud L, Jaureguy F, Frapy E, Guigon G, Gouriou S, Carbonnelle E, Clermont O, Denamur E, Picard B, Lemichez E, Brisse S, Nassif X. 2013. Severity of Escherichia coli bacteraemia is independent of the intrinsic virulence of the strains assessed in a mouse model. Clin Microbiol Infect 19:85-90. http://dx.doi.org/10.1111/j.1469-0691.2011.03750.x.
209. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S. 2004. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 303:1522-1526. http://dx.doi.org/10.1126/science.1094351.
210. Mathur R, Oh H, Zhang D, Park SG, Seo J, Koblansky A, Hayden MS, Ghosh S. 2012. A mouse model of Salmonella Typhi infection. Cell 151:590-602. http://dx.doi.org/10.1016/j.cell.2012.08.042.
211. Ewers C, Janssen T, Wieler LH. 2003. Avian pathogenic Escherichia coli (APEC). Berl Munch Tierarztl Wochenschr 116:381-395. (In German).
212. Tan C, Xu Z, Zheng H, Liu W, Tang X, Shou J, Wu B, Wang S, Zhao GP, ChenH. 2011. Genome sequence of a porcine extraintestinal pathogenic Escherichia coli strain. J Bacteriol 193:5038. http://dx.doi.org/10.1128/JB.05551-11.
213. Shpigel NY, Elazar S, Rosenshine I. 2008. Mammary pathogenic Escherichia coli. Curr Opin Microbiol 11:60-65. http://dx.doi.org/10.1016/j.mib.2008.01.004.
214. White JD, Stevenson M, Malik R, Snow D, Norris JM. 2013. Urinary tract infections in cats with chronic kidney disease. J Feline Med Surg 15:459-465. http://dx.doi.org/10.1177/1098612X12469522.
215. Jessen LR, Sorensen TM, Bjornvad CR, Nielsen SS, Guardabassi L. 2015. Effect of antibiotic treatment in canine and feline urinary tract infections: a systematic review. Vet J 203:270-277. http://dx.doi.org/10.1016/j.tvjl.2014.12.004.
216. Isling LK, Aalbaek B, Birck MM, Heegaard PM, Leifsson PS. 2011. Host response to porcine strains of Escherichia coli in a novel pyelonephritis model. J Comp Pathol 144:257-268. http://dx.doi.org/10.1016/j.jcpa.2010.10.002.
217. Farhat W, Traubici J, Sherman C, Williams T, Babyn P, McLorie G. 2002. Reliability of contrast enhanced sonography with harmonic imaging for detecting early renal scarring in experimental pyelonephritis in a porcine model: preliminary results. J Urol 168:1114-1117. http://dx.doi.org/10.1016/S0022-5347 (05) 64603-4.
218. Coulthard MG, Flecknell P, Orr H, Manas D, O'Donnell M. 2002. Renal scarring caused by vesicoureteric reflux and urinary infection: a study in pigs. Pediatr Nephrol 17:481-484. http://dx.doi.org/10.1007/s00467-002-0878-2.
219. Coulthard MG. 2002. Do kidneys outgrow the risk of reflux nephropathy? Pediatr Nephrol 17:477-480. http://dx.doi.org/10.1007/s00467-002-0877-3.
220. Asscher AW. 1979. Renal damage due to urinary tract infection. Contrib Nephrol 16:5-10. http://dx.doi.org/10.1159/000402865.
221. Akil I, Ozkinay F, Onay H, Canda E, Gumuser G, Kavukcu S. 2012. Assessment of Toll-like receptor-4 gene polymorphism on pyelonephritis and renal scar. Int J Immunogenet 39:303-307. http://dx.doi.org/10.1111/j.1744-313X.2012.01090.x.
222. Antao EM, Glodde S, Li G, Sharifi R, Homeier T, Laturnus C, Diehl I, Bethe A, Philipp HC, Preisinger R, Wieler LH, Ewers C. 2008. The chicken as a natural model for extraintestinal infections caused by avian pathogenic Escherichia coli (APEC). Microb Pathog 45:361-369. http://dx.doi.org/10.1016/j.micpath.2008.08.005.
223. Rodriguez-Siek KE, Giddings CW, Doetkott C, Johnson TJ, Fakhr MK, Nolan LK. 2005. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. Microbiology 151:2097-2110. http://dx.doi.org/10.1099/mic.0.27499-0.
224. Kariyawasam S, Scaccianoce JA, Nolan LK. 2007. Common and specific genomic sequences of avian and human extraintestinal pathogenic Escherichia coli as determined by genomic subtractive hybridization. BMC Microbiol 7:81. http://dx.doi.org/10.1186/1471-2180-7-81.
225. Ewers C, Li G, Wilking H, Kiessling S, Alt K, Antao EM, Laturnus C, Diehl I, Glodde S, Homeier T, Bohnke U, Steinruck H, Philipp HC, Wieler LH. 2007. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they? Int J Med Microbiol 297:163-176. http://dx.doi.org/10.1016/j.ijmm.2007.01.003.
226. Moulin-Schouleur M, Reperant M, Laurent S, Bree A, Mignon-Grasteau S, Germon P, Rasschaert D, Schouler C. 2007. Extraintestinal pathogenic Escherichia coli strains of avian and human origin: link between phylogenetic relationships and common virulence patterns. J Clin Microbiol 45:3366-3376. http://dx.doi.org/10.1128/JCM.00037-07.
227. Skyberg JA, Johnson TJ, Johnson JR, Clabots C, Logue CM, Nolan LK. 2006. Acquisitionof avian pathogenic Escherichia coli plasmids byacommensal E. Coli isolate enhances its abilities to kill chicken embryos, grow in human urine, and colonize the murine kidney. Infect Immun 74:6287-6292. http://dx.doi.org/10.1128/IAI.00363-06.
228. Zhao L, Gao S, Huan H, Xu X, Zhu X, Yang W, Gao Q, Liu X. 2009. Comparison of virulence factors and expression of specific genes between uropathogenic Escherichia coli and avian pathogenic E. Coli in a murine urinary tract infection model and a chicken challenge model. Microbiology 155:1634-1644. http://dx.doi.org/10.1099/mic.0.024 869-0.
229. Palaniyandi S, Mitra A, Herren CD, Lockatell CV, Johnson DE, Zhu X, Mukhopadhyay S. 2012. BarA-UvrY two-component system regulates virulence of uropathogenicE. Coli CFT073. PLoS One 7:e31348. http://dx.doi.org/10.1371/journal.pone.0031348.
230. Szmolka A, Nagy B. 2013. Multidrug resistant commensal Escherichia coli in animals and its impact for public health. Front Microbiol 4:258. http://dx.doi.org/10.3389/fmicb.2013.00258.
231. Wiles TJ, Bower JM, Redd MJ, Mulvey MA. 2009. Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli. PLoS Pathog 5:e1000697. http://dx.doi.org/10.1371/journal.ppat.1000697.
232. Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, Blanco J, O'Callaghan D, Nicolas-Chanoine MH. 2012. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7:e34294. http://dx.doi.org/10.1371/journal.pone.0034294.
233. van der Vaart M, Spaink HP, Meijer AH. 2012. Pathogen recognition and activation of the innate immune response in zebrafish. Adv Hematol 2012:159807. http://dx.doi.org/10.1155/2012/159807.
234. Trede NS, Langenau DM, Traver D, Look AT, Zon LI. 2004. The use of zebrafish to understand immunity. Immunity 20:367-379. http://dx.doi.org/10.1016/S1074-7613 (04) 00084-6.
235. Lieschke GJ. 2001. Zebrafish-an emerging genetic model for the study of cytokines and hematopoiesis in the era of functional genomics. Int J Hematol 73:23-31. http://dx.doi.org/10.1007/BF02981899.
236. Jault C, Pichon L, Chluba J. 2004. Toll-like receptor gene family and TIR-domain adapters in Danio rerio. Mol Immunol 40:759-771. http://dx.doi.org/10.1016/j.molimm.2003.10.001.
237. Li X, Wang S, Qi J, Echtenkamp SF, Chatterjee R, Wang M, Boons GJ, Dziarski R, Gupta D. 2007. Zebrafish peptidoglycan recognition proteins are bactericidal amidases essential for defense against bacterial infections. Immunity 27:518-529. http://dx.doi.org/10.1016/j.immuni.2007.07.020.
238. Dahlem TJ, Hoshijima K, Jurynec MJ, Gunther D, Starker CG, Locke AS, Weis AM, Voytas DF, Grunwald DJ. 2012. Simple methods for generating and detecting locus-specific mutations induced with TALENs in the zebrafish genome. PLoS Genet 8:e1002861. http://dx.doi.org/10.1371/journal.pgen. 1002861.
239. Ota S, Hisano Y, Ikawa Y, Kawahara A. 2014. Multiple genome modifications by the CRISPR/Cas9 system in zebrafish. Genes Cells 19:555-564. http://dx.doi.org/10.1111/gtc.12154.
240. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, Parant JM, Yost HJ, Kanki JP, Chien CB. 2007. The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn 236:3088-3099. http://dx.doi.org/10.1002/dvdy.21343.
241. Auer TO, Del Bene F. 2014. CRISPR/Cas9 and TALEN-mediated knock-in approaches in zebrafish. Methods 69:142-150. http://dx.doi.org/10.1016/j.ymeth.2014.03.027.
242. Hilbert DW, Paulish-Miller TE, Tan CK, Carey AJ, Ulett GC, Mordechai E, Adelson ME, Gygax SE, Trama JP. 2012. Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production. Microbes Infect 14:628-638. http://dx.doi.org/10.1016/j.micinf.2012.01.010.
243. Debnath I, Norton JP, Barber AE, Ott EM, Dhakal BK, Kulesus RR, Mulvey MA. 2013. The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli. Infect Immun 81:1450-1459. http://dx.doi.org/10.1128/IAI.01213-12.
244. Diard M, Baeriswyl S, Clermont O, Gouriou S, Picard B, Taddei F, Denamur E, Matic I. 2007. Caenorhabditis elegans as a simple model to study phenotypic and genetic virulence determinants of extraintestinal pathogenic Escherichia coli. Microbes Infect 9:214-223. http://dx.doi.org/10.1016/j.micinf.2006.11.009.
245. Lavigne JP, Blanc-Potard AB, Bourg G, Moreau J, Chanal C, Bouziges N, O'Callaghan D, Sotto A. 2006. Virulence genotype and nematodekilling properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases. Clin Microbiol Infect 12:1199-1206. http://dx.doi.org/10.1111/j.1469-0691.2006.01536.x.
246. Timmons L, Fire A. 1998. Specific interference by ingested dsRNA. Nature 395:854. http://dx.doi.org/10.1038/27579.
247. Timmons L, Court DL, Fire A. 2001. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene 263:103-112. http://dx.doi.org/10.1016/S0378-1119 (00) 00579-5.
248. Ewbank JJ, Zugasti O. 2011. C. elegans: model host and tool for antimicrobial drug discovery. Dis Model Mech 4:300-304. http://dx.doi.org/10.1242/dmm.006684.
249. Adiba S, Nizak C, van Baalen M, Denamur E, Depaulis F. 2010. From grazing resistance to pathogenesis: the coincidental evolution of virulence factors. PLoS One 5:e11882. http://dx.doi.org/10.1371/journal.pone.0011882.
250. Williamson DA, Mills G, Johnson JR, Porter S, Wiles S. 2014. In vivo correlatesof molecularly inferred virulence among extraintestinal pathogenicEscherichia coli (ExPEC) in the wax moth Galleria mellonella model system. Virulence 5:388-393. http://dx.doi.org/10.4161/viru.27912.
251. Alghoribi MF, Gibreel TM, Dodgson AR, Beatson SA, Upton M. 2014. Galleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E. Coli. PLoS One 9:e101547. http://dx.doi.org/10.1371/journal.pone.0101547.
252. Ciesielczuk H, Betts J, Phee L, Doumith M, Hope R, Woodford N, Wareham DW. 2015. Comparative virulence of urinary and bloodstream isolates of extra-intestinal pathogenic Escherichia coli in a Galleria mellonella model. Virulence 6:145-151. http://dx.doi.org/10.4161/21505594.2014.988095.
253. Boen JR, Sylwester D. 1966. A quantitative discussion of the effectiveness of voiding as a defense against bladder infection. Biometrics 22:53-57. http://dx.doi.org/10.2307/2528213.
254. Wolf DM, Arkin AP. 2002. Fifteen minutes of fim: control of type 1 pili expression in E. Coli. OMICS 6:91-114. http://dx.doi.org/10.1089/15362310252780852.